Vérane Schwiertz

Commercial <scp>anti‐CD19 CAR</scp> T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center

Pierre Sesques, Emmanuelle Ferrant, Violaine Safar et al. · American Journal of Hematology · 2020 · 135 citations · Full text

Medicine, Hematology, Oncology +16

Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs

Florence Ranchon, Gilles Salles, Hans-Martin Späth et al. · BMC Cancer · 2011 · 119 citations · Full text

Medicine, Oncology, Pharmacoeconomics +11

Hypersensitivity to oxaliplatin: clinical features and risk factors

Marie Parel, Florence Ranchon, Audrey Nosbaum et al. · BMC Pharmacology and Toxicology · 2014 · 104 citations · Full text

Medicine, Oncology, Pharmacology +15

Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells

Pierre Sesques, Jérémie Tordo, Emmanuelle Ferrant et al. · Clinical Nuclear Medicine · 2021 · 81 citations

Medicine, Oncology, Hematologic Oncology +15

Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Michaël Philippe, Florence Ranchon, Lila Gilis et al. · Biology of Blood and Marrow Transplantation · 2015 · 79 citations · Full text

Pharmacy, Hematology, Infectious Diseases +14